# Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

> **NCT01257776** · PHASE1,PHASE2 · COMPLETED · sponsor: **Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud** · enrollment: 33 (actual)

## Conditions studied

- Critical Limb Ischemia (CLI)
- Diabetes

## Interventions

- **DRUG:** Autologous adipose derived mesenchymal stem cells

## Key facts

- **NCT ID:** NCT01257776
- **Lead sponsor:** Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-02
- **Final completion:** 2015-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257776, "Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01257776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*